About 2 900 reports

Latvia Pharmaceuticals and Healthcare Report Q2 2015

103 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Market growth forecasts are strong although the country will continue to present a modest opportunity to larger multinational companies on account of its relatively small market size. Meanwhile, tensions between Ukraine and Russia may provide challenges for local manufacturers...

915 1 208 759
Apr 2015

China Pharmaceuticals and Healthcare Report Q2 2015

198 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Pharmaceutical sales in China will continue to grow robustly - boosted by the improvement in healthcare access, liberalisation of the industry as well as an epidemiological transition towards chronic diseases. This will present strong revenue earning opportunities for...

915 1 208 759
Apr 2015

Botswana Pharmaceuticals and Healthcare Report Q2 2015

66 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: With Botswana's plans to manufacture drugs locally stalling, the country will remain reliant on importing its pharmaceutical needs for the foreseeable future. The government's commitment to healthcare sector development will continue driving import growth to outperform...

915 1 208 759
Apr 2015

Zambia Pharmaceuticals and Healthcare Report Q2 2015

63 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The newly-elected government has already made some healthcare promises to the people of Zambia, such as its pledge to ensure the creation of 650 health clinics. However, there remains much political and economic uncertainty in the country, with President Edgar Lungu having...

915 1 208 759
Apr 2015

Brazil Pharmaceuticals and Healthcare Report Q2 2015

144 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Continued regulatory improvements, growing pharmaceutical and healthcare markets, and increased favour for foreign investment will allow Brazil to maintain its position as the regional outperformer in Latin America. However, low affordability and increasing generic drug...

915 1 208 759
Apr 2015

Austria Pharmaceuticals and Healthcare Report Q2 2015

71 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offeringsome of the most attractive opportunities in the region. Our updated forecasts indicate a continuing moderate rebound in both pharmaceutical and healthcare expenditure in 2015...

915 1 208 759
Apr 2015

China Vacuum Blood Collection Industry Report, 2014-2017

96 pages • By Research In China

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it into specimens prior to blood analysis. As a key integral part of the vacuum blood collection system, vacuum blood collection tubes get...

1 760 2 200 1 408
Mar 2015

South Korea Medical Tourist Arrivals and Spending Forecast To 2020

89 pages • By Igate Research

The medical tourism industry in South Korea is rapidly growing. The strength of Korea’s medical tourism lies in its highly skilled medical professionals, state-of-the art medical equipment, and well-established medical infrastructure. South Korea medical tourism market is likely to nearly quadruple by the year 2020 from the 2014 level. China...

720 900 576
Mar 2015

United States Medical Devices Report Q2 2015

178 pages • By Espicom Business Intelligence

The US medical market is forecast to see steady growth over the next five years, despite a projected slowdown in health spending, the impact of the newly introduced Medical Device Excise Tax and uncertainties within the healthcare system in the wake of the Patient Protection and Affordable Care Act. Imports have been growing in line with the...

976 1 317 810
Mar 2015

Herbal/Traditional Products in Croatia

23 pages • By Euromonitor International

Croatian consumers are increasingly considering how consumer health products may affect their body and possible side effects. Traditionally, herbal/traditional products are considered to be less hazardous if used as an alternative to standard products. This trend of using herbal/traditional alternatives has accelerated over the past few years.Euromonitor...

540 718 481
Mar 2015

Consumer Health in Croatia

69 pages • By Euromonitor International

The Croatian economy continued to perform poorly in 2014 – a situation which also negatively impacted the country’s consumer health market, albeit not to the same extent as in other FMCG markets. Health is one of the last areas where consumers look to save and make sacrifices. In addition, poor economic conditions and high unemployment bring...

1 440 1 915 1 282
Mar 2015

Philippines Pharmaceuticals and Healthcare Report Q2 2015

129 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Philippine government will face growing headwinds in attracting innovative drugmakers to expand their operations in the country due to the rising domestic use of generic drugs and the logistical risks preventing companies from using it as a regional distribution hub....

985 1 300 818
Mar 2015

Qatar Pharmaceuticals and Healthcare Report Q2 2015

104 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: With Qatar being the least exposed of the Gulf Cooperation Council (GCC) countries to lower oil prices, government spending on healthcare will remain elevated. Access to medicines will be improved following the implementation of the second phase of the GCC drug price...

985 1 300 818
Mar 2015

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015

84 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, causing the country's healthcare system to continue to rely on funding from donor partners and developmental agencies. Political and economic uncertainty will continue...

985 1 300 818
Mar 2015

Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015

82 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved healthcare access. While many opportunities may arise for market players, Sri Lanka is burdened by a prevalence of corruption and price controls, while also being...

985 1 300 818
Mar 2015

United States Pharmaceuticals and Healthcare Report Q2 2015

124 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The US pharmaceutical market's status as the most lucrative globally is unassailable. This is due to unparalleled healthcare access, considerable spending power, a high burden of disease, minimal market access barriers and intense company activity. The key risks to this...

985 1 300 818
Mar 2015

Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2015

128 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Saudi Arabia will deliver on its intentions to increase spending for the healthcare sector in 2015, despite lower oil prices. The government regards the sector as pivotal to political stability and we believe that actual spending will yet again exceed the amount budgeted...

985 1 300 818
Mar 2015

Bahrain Pharmaceuticals and Healthcare Report Q2 2015

100 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: We uphold our view that Bahrain's pharmaceutical and healthcare sector will maintain strong and consistent growth over our forecast period. We believe that the country's ageing population will help drive medicine demand along with an increasing chronic disease burden...

985 1 300 818
Mar 2015

Finland Pharmaceuticals and Healthcare Report Q2 2015

75 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Finland's pharmaceutical sector's growth is slowing, as is the case with many other mature western countries. The government is continually looking to new reforms and price control policies as it attempts to reduce spiralling healthcare costs associated with the country's...

985 1 300 818
Mar 2015

Angola Pharmaceuticals and Healthcare Report Q2 2015

64 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Due to its importance in the country's continued economic diversification and the government'sfocus on retaining political stability, government spending on healthcare in Angola will remain unaffectedby any potential budget cuts resulting from declining oil prices....

985 1 300 818
Mar 2015

Belarus Pharmaceuticals and Healthcare Report Q2 2015

88 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The volatility of the Belarusian rouble and high inflation will hurt consumer incomes and therefore the growth outlook of the pharmaceutical market over the next two years. Furthermore, increased scrutiny by President Lukashenko over pharmaceutical imports indicates that...

985 1 300 818
Mar 2015

Cuba Pharmaceuticals and Healthcare Report Q2 2015

76 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Cuban government's strong commitment to its pharmaceutical and healthcare sector, as shown through growing investment, will ensure the continued development of Cuba's healthcare market. Recent talks between Cuba and the US, increases to trade relations which boost...

985 1 300 818
Mar 2015

HER-2 Positive Breast Cancer Market in the US 2015-2019

108 pages • By Infiniti Research Limited

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated...

2 400 3 000 1 920
Mar 2015

Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015

63 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are commonplace. The state is also heavily reliant on importing its medicines, though over the long-term we believe this reliance will decrease as the government is committed to developing domestic...

985 1 300 818
Mar 2015

Business Strategy: Crossing the Innovation Gap from 2nd Platform to 3rd Platform Acute Care Systems -- The athenahealth and BIDMC Collaboration

9 pages • By IDC

This IDC Health Insights report discusses the changing U.S. healthcare system and the role technology suppliers will play in creating the next generation of health information system (HIS) and electronic health record (EHR) software to support successful value-based healthcare organizations (HCOs) in the context of a recently announced...

3 600 4 500 2 880
Mar 2015

Market Study on Upcoming Smart Cities in India, 2015

170 pages • By TechSci Research

A smart city employs high-end technology infrastructure that includes comprehensive IT infrastructure, a network of sensors, cameras, wireless devices and data centers for efficient and effective delivery of essential services such as electricity, water supply, sanitation, recycling, managing traffic, transportation systems, etc. Broader elements...

2 000 2 500 1 600
Mar 2015

Cough, Cold and Allergy (Hay Fever) Remedies in China

38 pages • By Euromonitor International

Value growth of cough, cold and allergy (hay fever) remedies (CCA) stabilised in 2014, at 8%, after a series of product safety issues since 2012. Firstly, ephedrine, one of the illegal drug making elements, was discovered in multinational CCA brands, such as New Contac and White & Black in 2012. Secondly, amantadine, hazardous to children’s...

540 718 481
Mar 2015

Vitamins and Dietary Supplements in China

51 pages • By Euromonitor International

With the improving living standards and the mounting pressure from life and work, more domestic consumers are demanding VDS to enhance their immune systems to improve their health. Their rising healthcare awareness and the growing pursuit of personal well-being well underpinned the continuous double-digit value growth in 2014. In addition,...

540 718 481
Mar 2015

Calming and Sleeping in China

27 pages • By Euromonitor International

With the accelerating lifestyles and mounting pressure from work and life, especially among urban consumers, more locals seem to have sleeping disorders, including difficulty falling asleep. An increasing number of consumers have resorted to calming and sleeping products for a better sleep, with growing healthcare consciousness, leading to...

540 718 481
Mar 2015

Eye Care in China

27 pages • By Euromonitor International

The Low-cost Common Drug List issued by the National Development and Reform Commission in May 2014, which was meant to make essential drugs more affordable to average consumers, impeded the value growth of OTC eye care. The low-price drugs in the list, including Chloramphenicol Eye Drops and Erythrocin Ointment usually sold at CNY1 per unit,...

540 718 481
Mar 2015